消化管内科

Medicine & Life Sciences

1. Crohn Disease 100%
2. Ulcerative Colitis 53%
3. Colonoscopy 41%
4. Ulcer 36%
5. Capsule Endoscopy 36%
6. Endoscopy 26%
7. Inflammatory Bowel Diseases 26%
8. Adenomatous Polyposis Coli 25%
9. Hemorrhage 23%
10. Infliximab 22%
11. Small Intestine 21%
12. Genome-Wide Association Study 21%
13. Helicobacter pylori 20%
14. Adalimumab 19%
15. Mucous Membrane 19%
16. Colitis 18%
17. Genes 18%
18. Narrow Band Imaging 16%
19. Population 15%
20. Stomach 14%
21. Therapeutics 14%
22. Japan 13%
23. Anti-Inflammatory Agents 13%
24. Adenoma 13%
25. Barium Enema 13%
26. Neoplasms 12%
27. Colorectal Neoplasms 12%
28. Recurrence 12%
29. Multicenter Studies 12%
30. Colon 11%
31. Microbiota 11%
32. Pharmaceutical Preparations 11%
33. Stomach Neoplasms 11%
34. Single Nucleotide Polymorphism 11%
35. Duodenal Neoplasms 11%
36. Primary Hypertrophic Osteoarthropathy 11%
37. Mutation 11%
38. Disease Susceptibility 11%
39. Radiography 10%
40. Endoscopic Mucosal Resection 10%
41. Cytokines 10%
42. Polyps 9%
43. Odds Ratio 9%
44. Prostaglandins 9%
45. Diarrhea 9%
46. Digestive System Endoscopy 8%
47. Endoscopic Hemostasis 8%
48. Duodenum 8%
49. Collagenous Colitis 8%
50. Double-Balloon Enteroscopy 8%
51. Gastric Mucosa 8%
52. HLA Antigens 8%
53. Esophageal Neoplasms 8%
54. Indigo Carmine 8%
55. Barium 7%
56. Gastrointestinal Hemorrhage 7%
57. Enteral Nutrition 7%
58. Duodenitis 7%
59. Sulindac 7%
60. Diverticular Diseases 7%
61. Celecoxib 7%
62. Marginal Zone B-Cell Lymphoma 7%
63. Atrophic Gastritis 7%
64. Confidence Intervals 7%
65. Germ-Line Mutation 7%
66. Gastrointestinal Endoscopy 6%
67. Biopsy 6%
68. Blood Vessels 6%
69. Incidence 6%
70. Alleles 6%
71. Cohort Studies 6%
72. Ileum 6%
73. Gastrointestinal Stromal Tumors 6%
74. Rectum 6%
75. Azathioprine 6%
76. Wounds and Injuries 6%
77. Lymphoma, Large B-Cell, Diffuse 6%
78. Tumor Necrosis Factor-alpha 6%
79. Abdominal Pain 6%
80. Adenocarcinoma 5%
81. Genotype 5%
82. Serum 5%
83. Retrospective Studies 5%
84. Vomiting 5%
85. Proton Pump Inhibitors 5%
86. Organic Anion Transporters 5%
87. Safety 5%
88. Anemia 5%
89. Shock 5%
90. Rectal Neoplasms 5%
91. Transverse Colon 5%
92. Phenotype 5%
93. Pepsinogen A 5%
94. Brunner Glands 5%
95. Jejunum 5%
96. Hypoproteinemia 5%